Combination of a imidazopyridazine derivative and a mitotic agent for the treatment of cancer

• 收藏
• 分享

专利权人:

Bayer Pharma Aktiengesellschaft

发明人:

Wengner, Antje Margret,Siemeister, Gerhard

申请号：

AU2014280224

公开号：

AU2014280224A1

申请日:

2014.06.11

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention relates to a combination comprising an Mps-1 kinase inhibitor and a mitotic inhibitor. The present invention also relates to the use of said combination for the treatment of cancer, in particular of pancreatic cancer, glioblastoma, ovarian cancer, non-small cell lung carcinoma, breast cancer and/or gastric cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/